In a 70-year-old patient weighing 70 kg who develops throat tightness, itching, and wheezing five minutes after receiving iodinated contrast media for an abdominal computed tomography scan, which medication should be administered immediately according to the American College of Radiology and American Academy of Allergy, Asthma & Immunology guidelines?

Immediate Management: Epinephrine 0.5 mg Intramuscularly

This patient should receive epinephrine 0.5 mg intramuscularly immediately—diphenhydramine should NOT be given as part of initial management. The correct answer is: Epinephrine 0.5 mg intramuscularly (option 3).

Clinical Reasoning

This 70-year-old patient presents with classic anaphylaxis to iodinated contrast media: throat tightness (airway involvement), pruritus (cutaneous manifestation), and wheezing (bronchospasm). This represents a multi-system immediate hypersensitivity reaction requiring urgent intervention.

Why Intramuscular Epinephrine Alone

According to the 2025 ACR/AAAAI consensus statement, intramuscular epinephrine is the first-line and most critical therapy for anaphylaxis 1. The guidelines are explicit that:

• Epinephrine counteracts the myriad mediators of anaphylaxis and arrests further mediator release
• The recommended dose is 0.01 mg/kg of 1:1000 concentration (1 mg/mL), with a maximum single dose of 0.5 mg for patients >50 kg 1
• Epinephrine should be administered into the vastus lateralis (anterolateral thigh) for optimal absorption 1
• There are no absolute contraindications to epinephrine for anaphylaxis, including age, cardiac disease, or frailty 1

Why NOT Intravenous Epinephrine

Intravenous epinephrine (1:10,000 concentration) is reserved only for rare cases of protracted anaphylaxis where symptoms remain continuous despite intramuscular dosing 1. Initial IV administration carries higher risk of cardiac complications and is not the standard first-line approach.

Why NOT Diphenhydramine as Initial Therapy

The guidelines explicitly state that all other therapies, including antihistamines, glucocorticoids, and bronchodilators should be secondarily considered after stabilization 1. Key points about antihistamines:

• H1 antihistamines address only cutaneous manifestations of anaphylaxis, none of which are life-threatening 1
• There is only indirect evidence supporting antihistamine use in anaphylaxis 1
• Antihistamines do not address the airway compromise or bronchospasm that threaten this patient's life

Critical Time Factor

Delay in administering epinephrine has been associated with anaphylaxis fatalities and increased risk of biphasic reactions 1. Early epinephrine administration may reduce the risk of biphasic anaphylaxis, which occurs in approximately 10.3% of ICM anaphylaxis cases 1, 2.

Common Pitfalls to Avoid

1. Do not wait to give antihistamines first—this delays life-saving epinephrine
2. Do not give IV epinephrine initially—IM route is safer and appropriate for initial management
3. Do not hesitate due to patient age or cardiac history—no absolute contraindications exist 1
4. Do not assume one dose is sufficient—be prepared to repeat in 5-15 minutes if symptoms persist or worsen

Subsequent Management

After epinephrine administration:

• Stop any ongoing ICM infusion immediately 1
• Position patient supine or Trendelenburg if hypotensive 1
• Administer supplemental oxygen for respiratory symptoms 1
• Consider fluid resuscitation if hypotensive 1
• Observe for at least 6 hours due to biphasic reaction risk (NPV 96.4%) 1, 2
• Transfer to emergency department for extended monitoring 1

The patient should be educated about the 10.3% risk of biphasic anaphylaxis, which can occur up to 72 hours later (mean 11 hours) 1, 2.